KIMBERLY TOUPS: Open Payments
NPI 1992980932 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 34 payments from 15 companies in 2025. Trend: 2023 $933 · 2024 $637 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Viatris Specialty LLC | 2 | $63 |
| ANI Pharmaceuticals, Inc. | 2 | $61 |
| United Therapeutics Corporation | 2 | $49 |
| Philips North America LLC | 3 | $46 |
| Electromed, Inc. | 6 | $43 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Verona Pharma, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
Products named: FASENRA, YUPELRI, PURIFIED CORTROPHIN GEL, Tyvaso, Vest Therapy Und, SMARTVEST, ZERBAXA, JASCAYD.
Industry payments across LA — which companies pay providers there.
